Data from week two of largest ongoing international market research study on COVID-19

New York, New York – April 8, 2020 – Week two data of the Barometer study from 5,000 physicians in 30 countries conducted by Sermo reveals the emergence of treatment patterns. Sermo, the largest global healthcare polling company and social platform for physicians, has published unrestricted access to the results of its Real Time Barometer study on sermo.com.  

Key findings:   

Usage patterns and efficacy perceptions among COVID treaters: 

  • The top three treatments that doctors most reported prescribing were Azithromycin (50%), Hydroxychloroquine (44%), and bronchodilators (36%) 
    • The treating physician percentage for Hydroxychloroquine went up across the board globally 
    • COVID treaters reported having prescribed or seen Hydroxychloroquine prescribed increase by 11% (from 33% to 44%) week over week and Azithromycin increase by 9% (from 41% to 50%) 
      • Italy had the highest increase in having prescribed or seen Hydroxychloroquine prescribed (from 50% to 71%). Reported usage in New York nearly doubled (23% to 40%), week over week. 

Read the original report here: https://www.sermo.com/press-releases/category/week-of-0406/

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »